Exact Mass: 317.0931
Exact Mass Matches: 317.0931
Found 70 metabolites which its exact mass value is equals to given mass value 317.0931,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N2-Monodes-methylnizatidine
[(E)-1-(methylamino)-2-nitroethenyl]({2-[({2-[(methylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl})amine
N2-Monodes-methylnizatidine is a metabolite of nizatidine. Nizatidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). It was developed by Eli Lilly and is marketed under the brand names Tazac and Axid. (Wikipedia)
N-2-Mdmn
Methyl[(4-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulphanyl]methyl}-1,3-thiazol-2-yl)methyl]amine
2-{2-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]hydrazono}-2-(methylsulfonyl)acetonitrile
2-{2-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]hydrazono}-2-(methylsulfonyl)acetonitrile
Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate
Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate
9(10H)-Acridinone, 1,4,5-trihydroxy-3,6-dimethoxy-10-methyl-
9(10H)-Acridinone, 1,4,5-trihydroxy-3,6-dimethoxy-10-methyl-
1, 3, 5-trihydroxy-2, 4-dimethoxy-10-methyl-10H-acridin-9-one|citruscridone
1, 3, 5-trihydroxy-2, 4-dimethoxy-10-methyl-10H-acridin-9-one|citruscridone
2,3-Dimethoxy-10-methyl-1,5,6-trihydroxyacridin-9(10H)-one
2,3-Dimethoxy-10-methyl-1,5,6-trihydroxyacridin-9(10H)-one
1,3,6-trihydroxy-4,5-dimethoxy-10-methylacridin-9-one
NCGC00385951-01!1,3,6-trihydroxy-4,5-dimethoxy-10-methylacridin-9-one
5,6-Dihydro-8,9-dimethoxypyrrolo[2,1-a]isoquinoline-2,3-dicarboxylic acid
5,6-Dihydro-8,9-dimethoxypyrrolo[2,1-a]isoquinoline-2,3-dicarboxylic acid
2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol
2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol
5-[(3,5-dimethoxybenzoyl)amino]-2-hydroxybenzoic acid
5-[(3,5-dimethoxybenzoyl)amino]-2-hydroxybenzoic acid
1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone
1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone
2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol
2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol
Methyl 4-(4-(Bis(2-Chloroethyl)Amino)Phenyl)Butyrate
Methyl 4-(4-(Bis(2-Chloroethyl)Amino)Phenyl)Butyrate
Benzoic acid, 4-[(3,5-dimethoxybenzoyl)amino]-2-hydroxy-
Benzoic acid, 4-[(3,5-dimethoxybenzoyl)amino]-2-hydroxy-
tert-butyl 4-[4-(chloromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate
tert-butyl 4-[4-(chloromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate
6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine,hydrochloride
6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine,hydrochloride
N-[(3S)-1-Chloro-5-methyl-2-oxohexan-3-yl]-4-methylbenzene-1-sulfonamide
N-[(3S)-1-Chloro-5-methyl-2-oxohexan-3-yl]-4-methylbenzene-1-sulfonamide
4-Amino-2-(phenacylthio)-5-pyrimidinecarboxylic acid ethyl ester
4-Amino-2-(phenacylthio)-5-pyrimidinecarboxylic acid ethyl ester
2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one
2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one
4-Sulfonamide-[4-(thiomethylaminobutane)]benzamide
4-Sulfonamide-[4-(thiomethylaminobutane)]benzamide
N-(2,3-dihydro-1H-inden-5-yl)-2-[(4-hydroxy-6-oxo-1H-pyrimidin-2-yl)thio]acetamide
N-(2,3-dihydro-1H-inden-5-yl)-2-[(4-hydroxy-6-oxo-1H-pyrimidin-2-yl)thio]acetamide
1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone
1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone
2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide
2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide
N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide
N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide
N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide
N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide
LY456236
LY456236
LY456236 is a selective, non-competitive and orally active mGlu1 receptor antagonist that inhibits phosphoinositide hydrolysis with an IC50 of 0.145 μM. LY456236 also inhibits EGFR with an IC50 of 0.91 μM[1][3].
(4ar,7s)-6,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium
(4ar,7s)-6,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium
atalafoline b
NA
{"Ingredient_id": "HBIN017264","Ingredient_name": "atalafoline b","Alias": "NA","Ingredient_formula": "C16H15NO6","Ingredient_Smile": "CN1C2=C(C=CC(=C2O)OC)C(=O)C3=C1C(=C(C=C3O)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1954","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-{[hydroxy(2-hydroxy-4-methoxyphenyl)methylidene]amino}-4-methoxybenzoic acid
2-{[hydroxy(2-hydroxy-4-methoxyphenyl)methylidene]amino}-4-methoxybenzoic acid
5-hydroxy-n-[2-hydroxy-4-(methoxycarbonyl)phenyl]-2-methoxybenzenecarboximidic acid
5-hydroxy-n-[2-hydroxy-4-(methoxycarbonyl)phenyl]-2-methoxybenzenecarboximidic acid
1,3,6-trihydroxy-2,5-dimethoxy-10-methylacridin-9-one
1,3,6-trihydroxy-2,5-dimethoxy-10-methylacridin-9-one
(12r,13s,18s)-8,12,14-trihydroxy-4-methyl-3,11-dioxa-15-azatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-1,4,7,9,14-pentaen-6-one
(12r,13s,18s)-8,12,14-trihydroxy-4-methyl-3,11-dioxa-15-azatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-1,4,7,9,14-pentaen-6-one
(s)-amino[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid
(s)-amino[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid
8,12,14-trihydroxy-4-methyl-3,11-dioxa-15-azatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-1,4,7,9,14-pentaen-6-one
8,12,14-trihydroxy-4-methyl-3,11-dioxa-15-azatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-1,4,7,9,14-pentaen-6-one
amino({3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl})acetic acid
amino({3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl})acetic acid
1,5,6-trihydroxy-2,3-dimethoxy-10-methylacridin-9-one
1,5,6-trihydroxy-2,3-dimethoxy-10-methylacridin-9-one
2-hydroxy-4,4,9-trimethyl-3,12,14-trioxa-9-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),6,10,15-tetraene-5,8-dione
2-hydroxy-4,4,9-trimethyl-3,12,14-trioxa-9-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),6,10,15-tetraene-5,8-dione
(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid
(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid
